Status:
COMPLETED
CardioBreathApp vs IMT in Heart Failure
Lead Sponsor:
Instituto de Cardiologia do Rio Grande do Sul
Conditions:
Congestive Heart Failure
Eligibility:
All Genders
40-70 years
Phase:
NA
Brief Summary
Heart failure (HF) is a systemic clinical syndrome defined as cardiac dysfunction, which causes inadequate blood supply to meet metabolic needs. One of the most expressive markers of HF is neurologic ...
Detailed Description
The impact of pulmonary, ventilatory and cardiovascular impairment in patients with congestive heart failure (CHF) highlights the therapeutic relevance of breathing exercises for these functions. In a...
Eligibility Criteria
Inclusion
- Consecutive CHF patients in treatment at the outpatient clinic (Institute of Cardiology)
- Of both sexes
- Aged between 40 and 70 years
- And ejection fraction (EF) reduced (\<40%)
- Who have access to a mobile device with access to Internet.
Exclusion
- active smoking
- BMI \<30
- Diagnosis of sleep apnea
- Heart failure of congenital origin
- Valve disease.
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2025
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT06139653
Start Date
December 1 2023
End Date
January 31 2025
Last Update
August 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiology Institute of Rio Grande do Sul
Porto Alegre, Rio Grande do Sul, Brazil